The profile of patients, out-of-treatment users and treating physicians involved in opioid maintenance treatment in Europe

Heroin Addiction and Related Clinical Problems

Volumn 14, Issue 4, 2012, Pages 7-22

  Goulão, João ^a   Stöver, Heino ^b  

^a General Directorate for Intervention on Addictive Behaviours and Dependencies   (Portugal)

^b FRANKFURT UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

OMT patient demographics; Out of treatment opioid user demographics; Treating physician demographics

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL PRACTICE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PRIORITY JOURNAL; SEX RATIO; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 84871636082     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. CLOUD W., GRANFIELD R. (2008): Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse 43: 1971-1986.
2. DIGIUSTO E., TRELOAR C. (2007): Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction 102: 958-969.
3. EMCDDA. (2010): Harm reduction: evidence, impacts and challenges. Last accessed 29 March 2012 at www.emcdda.europa.eu.
4. EMCDDA. (2011): 2011 Annual report on the state of the drugs problem in Europe. Last accessed 30 October 2012 at www.emcdda.europa.eu.
5. EMCDDA. (2011): Country overview: Greece. Last accessed 15 August 2012 at http://www.emcdda.europa.eu/publications/country-overviews/el.
6. EMCDDA. (2012): Country overview: Italy. Last accessed 15 August 2012 at http://www.emcdda.europa.eu/publications/country-overviews/it.
7. EMCDDA. (2012): Statistical bulletin 2012. Last accessed 10 August 2012 at www.emcdda.europa.eu//stats12/list.
8. FISCHER G., STÖVER H. (2012): Assessing the current state of opioid-dependence treatment across Europe: methodology of the European Quality Audit of Opioid Treatment (EQUATOR) project. Heroin Addict Relat Clin Probl 14: 5-70.
9. GOSSOP M., MARSDEN J., STEWART D. (2001): NTORS after five years (National Treatment Outcome Research Study): changes in substance use, health and criminal behaviour in the five years after intake. Department of Health research report. Last accessed 31 January 2012 at www.dh.gov.uk.
10. HM GOVERNMENT. (2010): Drug strategy 2010: Reducing demand, restricting supply, building recovery: supporting people to live a drug free life. Last accessed 15 March 2012 at www.homeoffice.gov.uk.
11. JONES A., DONMALL M., MILLAR T., MOODY A., WESTON S., and ANDERSON T. (2009): The Drug Treatment Outcomes Research Study (DTORS): final outcomes report. Research Report 24. Last accessed 8 June 2012 at www.dtors.org.uk.
12. JONES A., WESTON S., MOODY A., MILLAR T., DOLLIN L., ANDERSON T., and DONMALL M. (2007): The Drug Treatment Outcomes Research Study (DTORS): baseline report. Research Report 3. Last accessed 13 August 2012 at www.dtors.org.uk.
13. MANCIA G., LAURENT S., Agabiti-Rosei E., AMBROSIONI E., BURNIER M., CAULFIELD M.J., CIFKOVA R., CLEMENT D., COCA A., DOMINICZAK A., ERDINE S., FAGARD R., FARSANG C., GRASSI G., HALLER H., HEAGERTY A., KJELDSEN S.E., KIOWSKI W., MALLION J.M., MANOLIS A., NARKIEWICZ K., NILSSON P., OLSEN M.H., RAHN K.H., REDON J., RODICIO J., RUILOPE L., SCHMIEDER R.E., Struijker-Boudier H.A., VAN ZWIETEN P.A., VIIGIMAA M., ZANCHETTI A. (2009): Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27: 2121-2158.
14. MCLELLAN A.T., LEWIS D.C., O'BRIEN C.P., KLEBER H.D. (2000): Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284: 1689-1695.
15. MEIERKORD H., BOON P., ENGELSEN B., GOCKE K., SHORVON S., TINUPER P., HOLTKAMP M. (2010): EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17: 348-355.
16. MICHELS I.I., STOVER H. (2012): Harm reduction--from a conceptual framework to practical experience: the example of Germany. Subst Use Misuse 47: 910-922.
17. RADCLIFFE P., STEVENS A. (2008): Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatised identities. Soc Sci Med 67: 1065-1073.
18. RONCERO C., FUSTE G., BARRAL C., RODRÍGUEZCINTAS L., Martínez-Luna N., Eiroa-Orosa F.J., CASAS M., ON BEHALF OF THE PROTEUS STUDY INVESTIGATORS. (2011): Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study. Heroin Addict Relat Clin Probl 13: 5-16.
19. SCHULTE B, GANSEFORT D., STÖVER H., REIMER J. (2009): Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung substituierter Opiatabhängiger. Suchttherapie 10: 125-130.
20. STÖVER H. (2011): Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians. Eur Addict Res 17: 44-54.
21. WITTCHEN H.U., APELT S.M., SOYKA M., GASTPAR M., BACKMUND M., GOLZ J., KRAUS M.R., TRETTER F., SCHAFER M., SIEGERT J., SCHERBAUM N., REHM J., BUHRINGER G. (2008): Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend 95: 245-257.
22. WITTCHEN H.U., BÜHRINGER G., REHM J. (2011): Ergebnisse und Schlussfolgerungen der PREMOS-Studie (Predictors, Moderators and Outcome of Substitution Treatment). Suchtmedizin in Forschung und Praxis 13: 199-299.
23. WORLD HEALTH ORGANIZATION. (2009): Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Last accessed 26 October 2012 at www.who.int